Article thumbnail

IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women

By Moira S Lewitt, Agneta Hilding, Kerstin Brismar, Suad Efendic, Claes-Göran Östenson and Kerstin Hall
Topics: Clinical Study
Publisher: BioScientifica
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1995). Altered relation between circulating levels of insulin-like growth factorbinding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
  2. (1991). Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica
  3. (1990). Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clinical Endocrinology
  4. (1999). Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization,
  5. Dose–response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin.
  6. (2007). Effect of liver fat on insulin clearance.
  7. (2008). from
  8. (2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology
  9. (2006). Gender-specific care of the patient with diabetes: review and recommendations. Gender Medicine
  10. (1995). Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus.
  11. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study.
  12. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis.
  13. (1992). Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.
  14. (2008). Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.
  15. (2000). Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. Atherosclerosis
  16. Insulin-like growth factor binding protein-1: recent findings and new directions.
  17. (2008). Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults.
  18. (1996). Insulin-like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women.
  19. (2008). Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia
  20. (2010). Lewitt and others
  21. (2009). Low levelsof insulin-like growthfactor-bindingprotein-1(IGFBP-1)are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the So ¨dera ˚kra Cardiovascular Risk Factor Study. Diabetes & Metabolism
  22. (1988). Metabolicregulationof thegrowthhormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinologica
  23. (1991). Oral contraceptives increase insulin-like growth factor binding protein-1 in women with polycytic ovarian disease. Fertility and Sterility
  24. Organisation. BMI Classification. Retrieved
  25. (2005). Prevention of type 2 diabetes. Current Molecular Medicine
  26. (2008). Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabetic Medicine
  27. (1996). Reduced insulinlike growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM).
  28. (1984). Roovete A & Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding potein isolated from human amniotic fluid. Acta Endocrinologica
  29. (1995). Rotnitzky A & Manson JE. Weight gain as a risk factorforclinical diabetes mellitusinwomen.Annalsof Internal Medicine
  30. (2005). Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men.
  31. (2005). Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.
  32. (2001). The insulin-like growth factor-I system and hormone replacement therapy. Fertility and Sterility
  33. (2004). The metabolic syndrome: an emerging health epidemic in women.
  34. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.
  35. (2001). White A & Gibson JM. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia